Mason, William J.
Jafree, Daniyal J.
Pomeranz, Gideon
Kolatsi-Joannou, Maria
Rottner, Antje K.
Pacheco, Sabrina
Moulding, Dale A.
Wolf, Anja
Kupatt, Christian
Peppiatt-Wildman, Claire
Papakrivopoulou, Eugenia
Riley, Paul R.
Long, David A.
Vasilopoulou, Elisavet http://orcid.org/0000-0002-1940-0333
Funding for this research was provided by:
Wellcome Trust (095949/Z/11/Z)
Medical Research Council (MR/P018629/1, MR/J003638/1)
Diabetes UK (17/0005733)
Kidney Research UK (PDF8/2015)
Article History
Received: 8 March 2022
Accepted: 7 July 2022
First Online: 16 July 2022
Competing interests
: AKR is now an employee of AstraZeneca and holds stocks in AstraZeneca. All experimental work by AKR was carried out during her studies at the UCL Great Ormond Street Institute of Child Health as part of the Cell and Gene Therapy MSc programme. The other authors have nothing to disclose.